Sector
Bio & Healthcare
36 deals in Bio & Healthcare.
| Date | Target | Acquirer | Value | Stage |
|---|---|---|---|---|
| Sep 15, 2026 | Ray Co. (26.14% stake) | Graphy | — | Closed |
| Jul 20, 2026 | PolyPeptide Group | Samsung Biologics | — | Announced |
| Jun 22, 2026 | Ultra V and ATGC | VIG Partners | — | Closed |
| Jun 18, 2026 | CG Bio | IMM Private Equity | — | Terminated |
| Feb 12, 2026 | Koru Pharma | LYFE Capital | — | Closed |
| Dec 23, 2025 | Kakao Healthcare | CHA Bio Group (CHA Cares, CHA AI Healthcare) | — | Closed |
| Aug 7, 2025 | LG Chem Aesthetics business | VIG Partners | — | Signed |
| Jul 9, 2025 | Viol | VIG Partners (Vienna SPC) | — | Closed |
| Jan 22, 2025 | Star Vision (OLENS) | CVC Capital Partners | — | Signed |
| Sep 6, 2024 | Hironic | Dongwha Pharmaceutical | — | Terminated |
| Aug 16, 2024 | Jeisys Medical | Archimed (Syracuse Subco) | — | Closed |
| Jul 16, 2024 | Genuone Sciences | Macquarie Asset Management | — | Closed |
| Apr 22, 2024 | Geo-Young (Chosun Hye GY Holdings) | MBK Partners | — | Closed |
| Dec 20, 2023 | AbTis | Dong-A ST | — | Announced |
| Oct 17, 2023 | Daekyung Oil & Transportation | SK Trading International / KDB / Eugene Private Equity consortium (SPC) | — | Signed |
| Oct 4, 2023 | LG Chem in-vitro diagnostics business (now Invitros) | Glenwood PE | — | Closed |
| Sep 4, 2023 | Ilooda | Classys (Bain Capital portfolio company) | — | Signed |
| Jun 9, 2023 | Lutronic | Hahn & Company (Hahn & Co 23) | — | Closed |
| Jun 2, 2023 | Stericycle Korea (and Envitec Korea) | Korea Wide Partners / NH Investment & Securities (co-GP project fund) | — | Closed |
| May 25, 2023 | EOFlow | Medtronic (Medtronic Korea Holdings) | — | Terminated |
| Apr 12, 2023 | Osstem Implant | Dentistry Investment (MBK Partners / UCK Partners consortium) | — | Closed |
| Feb 24, 2023 | Taewoong Medical | Olympus Corporation (Japan) | — | Signed |
| Feb 23, 2023 | Boryung Biopharma | Dongwon Industries | — | Terminated |
| Jan 18, 2023 | Carelabs | Wonik Holdings | — | Closed |
| Nov 22, 2022 | PanGen Biotech | CrystalGenomics | — | Announced |
| Sep 16, 2022 | Korea Biopharm | DxVx | — | Closed |
| Jul 28, 2022 | Bodyfriend | Stonebridge Capital & Hahn & Brothers (BF Heart SPC) | — | Closed |
| Jul 4, 2022 | Starvision (OLENS) | Founder Park Sang-jin | — | Closed |
| May 31, 2022 | AIM | HLB Life Science | — | Signed |
| Apr 19, 2022 | Poseung Green Power | LX International | — | Announced |
| Apr 4, 2022 | Samsung Bioepis 50%-1 share stake | Samsung Biologics | — | Closed |
| Mar 17, 2022 | Medipost | Skylake–Crescendo consortium | — | Signed |
| Jan 27, 2022 | Classys | Bain Capital | — | Closed |
| Aug 25, 2021 | Hugel | GS Group consortium (Aphrodite Acquisition Holdings: GS, CBC Group, Mubadala, IMM Investment) | — | Signed |
| Jul 30, 2021 | Dosi Hwangyeong, E-Medione, Green Environment Technology (3 medical-waste incinerators) | SK ecoplant | — | Closed |
| Jul 21, 2021 | ChunLab (now CJ Bioscience) | CJ CheilJedang | — | Announced |